162 related articles for article (PubMed ID: 32742599)
1. Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells
Kouhpaikar H; Sadeghian MH; Rafatpanah H; Kazemi M; Iranshahi M; Delbari Z; Khodadadi F; Ayatollahi H; Rassouli FB
Iran J Basic Med Sci; 2020 May; 23(5):616-622. PubMed ID: 32742599
[TBL] [Abstract][Full Text] [Related]
2. Combination of auraptene and arsenic trioxide induces apoptosis and cellular accumulation in the subG1 phase in adult T-cell leukemia cells.
Kazemi M; Kouhpeikar H; Delbari Z; Khodadadi F; Gerayli S; Iranshahi M; Mosavat A; Behnam Rassouli F; Rafatpanah H
Iran J Basic Med Sci; 2021 Dec; 24(12):1643-1649. PubMed ID: 35432798
[TBL] [Abstract][Full Text] [Related]
3. Galbanic Acid Improves Accumulation and Toxicity of Arsenic Trioxide in MT-2 Cells.
Mahdifar M; Rassouli FB; Iranshahi M; Goudarzi S; Golizadeh M; Rafatpanah H
Anticancer Agents Med Chem; 2023; 23(6):699-708. PubMed ID: 35899960
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
Nasrollahzadeh A; Bashash D; Kabuli M; Zandi Z; Kashani B; Zaghal A; Mousavi SA; Ghaffari SH
Life Sci; 2020 Sep; 257():118060. PubMed ID: 32645343
[TBL] [Abstract][Full Text] [Related]
5. Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells.
Yi J; Gong X; Yin XY; Wang L; Hou JX; Chen J; Xie B; Chen G; Wang LN; Wang XY; Wang DC; Wei HL
Front Oncol; 2022; 12():988528. PubMed ID: 36353537
[TBL] [Abstract][Full Text] [Related]
6. c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis.
Sayyadi M; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Abolghasemi H; Anoushirvani AA; Bashash D
Arch Med Res; 2020 Oct; 51(7):636-644. PubMed ID: 32553459
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO).
Alipour F; Riyahi N; Safaroghli-Azar A; Sari S; Zandi Z; Bashash D
Int J Biochem Cell Biol; 2019 Nov; 116():105615. PubMed ID: 31539632
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide induces the apoptosis and decreases NF-κB expression in lymphoma cell lines.
Zhong L; Xu F; Chen F
Oncol Lett; 2018 Nov; 16(5):6267-6274. PubMed ID: 30333888
[TBL] [Abstract][Full Text] [Related]
9. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Nuclear Factor-Κb (NF-Κb) Pathway Using Bay 11-7082 Enhances Arsenic Trioxide-Induced Antiproliferative Activity in U87 Glioblastoma Cells.
Nasrollahzadeh A; Momeny M; Bashash D; Yousefi H; Mousavi SA; Ghaffari SH
Rep Biochem Mol Biol; 2022 Jan; 10(4):602-613. PubMed ID: 35291620
[TBL] [Abstract][Full Text] [Related]
11. Physiologic Doses of Ascorbic Acid Increase Arsenic Trioxide Toxicity in Human Jurkat -T Lymphoma Cells.
Yedjou CG; Byrd R; Allen L; Tchounwou PB
Met Ions Biol Med; 2011; 11():236-241. PubMed ID: 26401102
[TBL] [Abstract][Full Text] [Related]
12.
Hachiman M; Yoshimitsu M; Ezinne C; Kuroki A; Kozako T; Arima N
Oncol Lett; 2018 Jul; 16(1):1305-1311. PubMed ID: 30061950
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
Dbaibo GS; Kfoury Y; Darwiche N; Panjarian S; Kozhaya L; Nasr R; Abdallah M; Hermine O; El-Sabban M; de Thé H; Bazarbachi A
Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
[TBL] [Abstract][Full Text] [Related]
14. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
[TBL] [Abstract][Full Text] [Related]
15. Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines.
Mohammadi Kian M; Haghi A; Salami M; Chahardouli B; Rostami SH; Malekzadeh K; Kamranzadeh Foumani H; Mohammadi S; Nikbakht M
Cell J; 2020 Jul; 22(2):193-202. PubMed ID: 31721534
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin A in A549 cell line after treatment with arsenic trioxide.
Żuryń A; Krajewski A; Litwiniec A; Klimaszewska-Wiśniewska A; Grzanka A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1259-67. PubMed ID: 26671917
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Duechler M; Stańczyk M; Czyz M; Stepnik M
Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
[TBL] [Abstract][Full Text] [Related]
18. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
[TBL] [Abstract][Full Text] [Related]
19. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
